Weekly IC Summary - 2026-01-18
High conviction ADD recommendations driven by regulatory tailwinds and insider buying signals across financials (JPM), pharma (PFE), and industrials (HON, MCD)
- High conviction ADD recommendations driven by regulatory tailwinds and insider buying signals across financials (JPM), pharma (PFE), and industrials (HON, MCD)
- Rising 10Y yields to 4.14% compress growth stock valuations despite strong fundamentals, creating tactical HOLD positions in MSFT, META, NVDA
- Heavy insider selling patterns across mega-cap tech remove upside conviction signals despite positive business momentum
- Regulatory easing across banking ($5.8T capacity), pharma (single-trial approvals), and manufacturing (tariff-driven reshoring) creates structural catalysts
- Member access required
- Member access required
- Member access required
Unlock Weekly IC Summary
Get full conviction changes, risk signals, and portfolio adjustments.
One click with SSO. Takes seconds.